Evommune director Arthur S. Kirsch reports purchase of $133,000 in common shares

• Evommune director Arthur S. Kirsch bought 10,000 common shares at USD 13.3, raising beneficial ownership to 10,000 shares held indirectly via a trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evommune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001290976-26-000004), on July 08, 2026, and is solely responsible for the information contained therein.